alexa A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women.


Journal of Womens Health Care

Author(s): Yang HM, Liao MF, Zhu SY, Liao MN, Rohdewald P

Abstract Share this page

Abstract BACKGROUND: French maritime pine bark extract (Pycnogenol) was found to alleviate menstrual pain and reduce hyperactivity in clinical studies. These results suggest the possibility to observe positive effects in treating climacteric syndrome. OBJECTIVE: Clinical investigation of the effect of Pycnogenol, French maritime pine bark extract, on the climacteric syndrome. METHODS: Some 200 peri-menopausal women were enrolled in a double-blind, placebo-controlled study, and treated with Pycnogenol (200mg) daily. Climacteric symptoms were evaluated by the Women's Health Questionnaire (WHQ), patients were checked for antioxidative status and routine chemistry. A total of 155 women completed the study. RESULTS: All climacteric symptoms improved, antioxidative status increased and LDL/HDL ratio was favourably altered by Pycnogenol. No side effects were reported. CONCLUSION: Pycnogenol may offer an alternative method to reducing climacteric symptoms without unwanted effects. This article was published in Acta Obstet Gynecol Scand and referenced in Journal of Womens Health Care

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version